(Total Views: 503)
Posted On: 04/26/2022 9:33:45 AM
Post# of 156187
True but why move around COO and have an opening for CEO? Maybe a partnership to prove ourselves and then a buyout?
Once again I don’t see a buyout at all anytime soon. We need that BLA done and behind us before BP starts making offers. I guess you are right they won’t let us run at it alone in the long run but i most definitely do not see a buyout anytime soon. We need a solid trial with an approval.
It’s going to take a partnership with a huge cash infusion to get us there.
Once again I don’t see a buyout at all anytime soon. We need that BLA done and behind us before BP starts making offers. I guess you are right they won’t let us run at it alone in the long run but i most definitely do not see a buyout anytime soon. We need a solid trial with an approval.
It’s going to take a partnership with a huge cash infusion to get us there.


Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com